NCT04471493

Brief Summary

Many ambulatory networks are mainly based on diagnoses made by first-line physicians not specifically trained to join the network. Here we aim to set up a surveillance network on pediatric infectious diseases with an investment in teaching with specific trainings of participating pediatricians, increasing in use of point of care tests, and automated data extraction from the computers of the pediatricians.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
400,000

participants targeted

Target at P75+ for all trials

Timeline
52mo left

Started Jun 2017

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress68%
Jun 2017Aug 2030

Study Start

First participant enrolled

June 26, 2017

Completed
3 years until next milestone

First Submitted

Initial submission to the registry

July 8, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 15, 2020

Completed
10 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 27, 2030

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 2, 2030

Last Updated

February 8, 2024

Status Verified

January 1, 2024

Enrollment Period

13 years

First QC Date

July 8, 2020

Last Update Submit

February 7, 2024

Conditions

Keywords

VaccinationAntibiotic treatmentPoint of care testautomated data extractionnetwork

Outcome Measures

Primary Outcomes (1)

  • Evaluation of the number of infectious diseases

    proportion of children under 16 years, with infectious disease

    5 years

Secondary Outcomes (2)

  • Evaluation of the use of point of care tests

    5 years

  • Evaluation of the antibiotic treatments

    5 years

Eligibility Criteria

Age1 Day - 16 Years
Sexall
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

Children under 16 years with infectious disease

You may qualify if:

  • Children under 16 years of age with at least one infectious disease among:
  • pharyngitis
  • otitis
  • pneumonia
  • influenza
  • bronchiolitisz
  • varicella
  • gastroenteritis
  • enterovirus disease
  • bordetella pertussis disease
  • using the same same software, Axi5-Infansoft (developed by CompuGroup Medical, Nanterre, France)

You may not qualify if:

  • parental refusal

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

AFPA

Créteil, France

RECRUITING

Related Publications (1)

  • Cohen R, Bechet S, Gelbert N, Frandji B, Vie Le Sage F, Thiebault G, Kochert F, Cahn-Sellem F, Werner A, Ouldali N, Levy C. New Approach to the Surveillance of Pediatric Infectious Diseases From Ambulatory Pediatricians in the Digital Era. Pediatr Infect Dis J. 2021 Jul 1;40(7):674-680. doi: 10.1097/INF.0000000000003116.

Related Links

MeSH Terms

Conditions

OtitisBronchiolitisInfluenza, HumanPharyngitisChickenpoxPneumoniaGastroenteritis

Condition Hierarchy (Ancestors)

Ear DiseasesOtorhinolaryngologic DiseasesBronchitisRespiratory Tract InfectionsInfectionsBronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesOrthomyxoviridae InfectionsRNA Virus InfectionsVirus DiseasesPharyngeal DiseasesStomatognathic DiseasesVaricella Zoster Virus InfectionHerpesviridae InfectionsDNA Virus InfectionsGastrointestinal DiseasesDigestive System Diseases

Study Officials

  • Robert Cohen

    Association Clinique et Thérapeutique Infantile du Val de Marne

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
5 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 8, 2020

First Posted

July 15, 2020

Study Start

June 26, 2017

Primary Completion (Estimated)

June 27, 2030

Study Completion (Estimated)

August 2, 2030

Last Updated

February 8, 2024

Record last verified: 2024-01

Locations